Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Lancet Respir Med. 2023 Mar;11(3):273-282. doi: 10.1016/S2213-2600(22)00364-2. Epub 2022 Oct 14.
Interest in lifetime lung function trajectories has increased in the context of emerging evidence that chronic obstructive pulmonary disease (COPD) can arise from multiple disadvantaged lung function pathways, including those that stem from poor lung function in childhood. To our knowledge, no previous study has investigated both obstructive and restrictive lifetime patterns concurrently, while accounting for potential overlaps between them. We aimed to investigate lifetime trajectories of the FEV/forced vital capacity (FVC) ratio, FVC, and their combinations, relate these combined trajectory groups to static lung volume and gas transfer measurements, and investigate both risk factors for and consequences of these combined trajectory groups.
Using z scores from spirometry measured at ages 7, 13, 18, 45, 50, and 53 years in the Tasmanian Longitudinal Health Study (n=2422), we identified six FEV/FVC ratio trajectories and five FVC trajectories via group-based trajectory modelling. Based on whether trajectories of the FEV/FVC ratio and FVC were low (ie, low from childhood or adulthood) or normal, four patterns of lifetime spirometry obstruction or restriction were identified and compared against static lung volumes and gas transfer. Childhood and adulthood characteristics and morbidities of these patterns were investigated.
The prevalence of the four lifetime spirometry patterns was as follows: low FEV/FVC ratio only, labelled as obstructive-only, 25·8%; low FVC only, labelled as restrictive-only, 10·5%; both low FEV/FVC ratio and low FVC, labelled as mixed, 3·5%; and neither low FEV/FVC ratio nor low FVC, labelled as reference, 60·2%. The prevalence of COPD at age 53 years was highest in the mixed pattern (31 [37%] of 84 individuals) followed by the obstructive-only pattern (135 [22%] of 626 individuals). Individuals with the mixed pattern also had the highest prevalence of parental asthma, childhood respiratory illnesses, adult asthma, and depression. Individuals with the restrictive-only pattern had lower total lung capacity and residual volume, and had the highest prevalence of childhood underweight, adult obesity, diabetes, cardiovascular conditions, hypertension, and obstructive sleep apnoea.
To our knowledge, this is the first study to characterise lifetime phenotypes of obstruction and restriction simultaneously using objective data-driven techniques and unique life course spirometry measures of FEV/FVC ratio and FVC from childhood to middle age. Mixed and obstructive-only patterns indicate those who might benefit from early COPD interventions. Those with the restrictive-only pattern had evidence of true lung restriction and were at increased risk of multimorbidity by middle age.
National Health and Medical Research Council of Australia, The University of Melbourne, Clifford Craig Medical Research Trust of Tasmania, The Victorian, Queensland & Tasmanian Asthma Foundations, The Royal Hobart Hospital, Helen MacPherson Smith Trust, and GlaxoSmithKline.
由于越来越多的证据表明,慢性阻塞性肺疾病(COPD)可以源自多种不利的肺功能途径,包括儿童时期肺功能不良的途径,因此人们对终生肺功能轨迹的兴趣有所增加。据我们所知,以前没有研究同时调查阻塞性和限制性终生模式,同时考虑它们之间的潜在重叠。我们的目的是研究 FEV/用力肺活量(FVC)比值、FVC 及其组合的终生轨迹,将这些联合轨迹组与静态肺容量和气体转移测量相关联,并研究这些联合轨迹组的风险因素和后果。
使用塔斯马尼亚纵向健康研究(n=2422)中 7、13、18、45、50 和 53 岁时的肺活量测定中的 z 分数,我们通过基于群组的轨迹建模确定了六个 FEV/FVC 比值轨迹和五个 FVC 轨迹。基于 FEV/FVC 比值和 FVC 轨迹是否低(即从儿童期或成年期开始低)或正常,确定了四种终生肺功能阻塞或限制模式,并与静态肺容量和气体转移进行了比较。研究了这些模式的儿童期和成年期特征以及发病情况。
四种终生肺功能模式的患病率如下:仅低 FEV/FVC 比值,标记为阻塞性,占 25.8%;仅低 FVC,标记为限制性,占 10.5%;低 FEV/FVC 比值和低 FVC 均有,标记为混合性,占 3.5%;低 FEV/FVC 比值和低 FVC 均无,标记为参考,占 60.2%。53 岁时 COPD 的患病率以混合模式最高(84 人中的 31 人[37%]),其次是仅阻塞性模式(626 人中的 135 人[22%])。混合模式的个体也有最高的父母哮喘、儿童呼吸道疾病、成年哮喘和抑郁患病率。仅限制性模式的个体总肺容量和残气量较低,儿童体重不足、成年肥胖、糖尿病、心血管疾病、高血压和阻塞性睡眠呼吸暂停的患病率最高。
据我们所知,这是第一项使用客观数据驱动技术并结合从儿童期到中年的 FEV/FVC 比值和 FVC 的独特生命历程肺活量测量来同时描述阻塞和限制的终生表型的研究。混合和仅阻塞模式表明那些可能受益于早期 COPD 干预的人群。仅限制性模式的个体具有真正的肺限制证据,并且到中年时多种疾病的风险增加。
澳大利亚国家健康与医学研究委员会、墨尔本大学、塔斯马尼亚州克利福德·克雷格医学研究信托基金、维多利亚州、昆士兰州和塔斯马尼亚州哮喘基金会、皇家霍巴特医院、海伦·麦克弗森·史密斯信托基金和葛兰素史克公司。